These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 21881031)

  • 1. Transient elevation of international normalized ratio during cisplatin-based chemotherapy in patients who are taking warfarin.
    Yano R; Kurokawa T; Tsuyoshi H; Shinagawa A; Sawamura Y; Matsunaga A; Nakamura T; Yoshida Y; Yoneda M; Kotsuji F; Masada M
    Ann Pharmacother; 2011 Oct; 45(10):e55. PubMed ID: 21881031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A potential interaction between warfarin and atovaquone.
    Hidalgo K; Lyles A; Dean SR
    Ann Pharmacother; 2011 Jan; 45(1):e3. PubMed ID: 21189363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Probable interaction between warfarin and antitumor agents used in R-ESHAP chemotherapy.
    Suzuki T; Koga H; Yamazaki S; Saeki H; Tanaka H; Nishimura M; Nakaseko C; Nakasa H; Nakamura H; Ariyoshi N; Kitada M
    Clin Ther; 2008 Jun; 30(6):1155-9. PubMed ID: 18640471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated International Normalized Ratio in a patient concurrently using warfarin and vismodegib.
    Lim S; Houranieh J; Crawford R
    Am J Health Syst Pharm; 2014 Feb; 71(3):200-3. PubMed ID: 24429012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of stress on international normalized ratio during warfarin therapy.
    Hawk TL; Havrda DE
    Ann Pharmacother; 2002 Apr; 36(4):617-20. PubMed ID: 11918508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential glucosamine-warfarin interaction resulting in increased international normalized ratio: case report and review of the literature and MedWatch database.
    Knudsen JF; Sokol GH
    Pharmacotherapy; 2008 Apr; 28(4):540-8. PubMed ID: 18363538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critically elevated INR in a patient on warfarin after increase in extended-release niacin dose.
    Christopher A
    Ann Pharmacother; 2011 Nov; 45(11):e58. PubMed ID: 22010004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistent drug interaction between aprepitant and warfarin in patients receiving anticancer chemotherapy.
    Ohno Y; Yamada M; Yamaguchi R; Hisaka A; Suzuki H
    Int J Clin Pharm; 2014 Dec; 36(6):1134-7. PubMed ID: 25288146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.
    Wong YM; Quek YN; Tay JC; Chadachan V; Lee HK
    J Clin Pharm Ther; 2011 Oct; 36(5):585-91. PubMed ID: 21070296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated international normalized ratio associated with use of dronedarone and warfarin.
    Pogge EK; Haber SL
    Ann Pharmacother; 2011 Sep; 45(9):e46. PubMed ID: 21811004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of oral diuretics on chronic warfarin therapy: a retrospective study.
    Edwards HD; Webb RD; Conway SE
    Expert Opin Drug Saf; 2012 May; 11(3):375-80. PubMed ID: 21957964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probable drug interaction between warfarin and hormonal contraceptives.
    Zingone MM; Guirguis AB; Airee A; Cobb D
    Ann Pharmacother; 2009 Dec; 43(12):2096-102. PubMed ID: 19934391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ifosfamide and etoposide chemotherapy may interact with warfarin, enhancing the warfarin induced anticoagulant response.
    Okada N; Watanabe H; Kagami S; Ishizawa K
    Int J Clin Pharmacol Ther; 2016 Jan; 54(1):58-61. PubMed ID: 26587904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of weekly irinotecan and cisplatin for refractory or recurrent non-small cell lung cancer.
    Takiguchi Y; Moriya T; Asaka-Amano Y; Kawashima T; Kurosu K; Tada Y; Nagao K; Kuriyama T
    Lung Cancer; 2007 Nov; 58(2):253-9. PubMed ID: 17658654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of Drug-Drug Interaction between Warfarin and Aprepitant and Its Effects on PT-INR of Patients Receiving Anticancer Chemotherapy.
    Takaki J; Ohno Y; Yamada M; Yamaguchi R; Hisaka A; Suzuki H
    Biol Pharm Bull; 2016 May; 39(5):863-8. PubMed ID: 26948084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A probable interaction between warfarin and the antiretroviral TRIO study regimen.
    Liedtke MD; Vanguri A; Rathbun RC
    Ann Pharmacother; 2012 Nov; 46(11):e34. PubMed ID: 23115227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levofloxacin and warfarin interaction.
    Jones CB; Fugate SE
    Ann Pharmacother; 2002 Oct; 36(10):1554-7. PubMed ID: 12243605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Capecitabine-warfarin interaction.
    Janney LM; Waterbury NV
    Ann Pharmacother; 2005 Sep; 39(9):1546-51. PubMed ID: 16014372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of warfarin and low range INR in the prevention of recurrent venous thrombosis].
    Quintero J; Torres E; Diez-Ewald M; Arteaga-Vizcaíno M; Vizcaíno G; León M; Rodríguez Z; Fernández N
    Invest Clin; 2011 Sep; 52(3):230-8. PubMed ID: 21950194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initiation of exemestane in two warfarin-treated patients leading to elevation and variability of INR.
    Dush A; Williams A; Mangini N; Klaczak K
    J Oncol Pharm Pract; 2016 Apr; 22(2):371-3. PubMed ID: 25596194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.